{"version":"1.0","provider_name":"SERB Pharmaceuticals","provider_url":"https:\/\/serb.com\/nl\/","title":"BTG plc: Voraxaze\u00ae (glucarpidase) receives US regulatory approval - SERB Pharmaceuticals","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"BsrbBfuceb\"><a href=\"https:\/\/serb.com\/nl\/news\/btg-plc-voraxaze-glucarpidase-receives-us-regulatory-approval\/\">BTG plc: Voraxaze\u00ae (glucarpidase) receives US regulatory approval<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/serb.com\/nl\/news\/btg-plc-voraxaze-glucarpidase-receives-us-regulatory-approval\/embed\/#?secret=BsrbBfuceb\" width=\"600\" height=\"338\" title=\"&#8220;BTG plc: Voraxaze\u00ae (glucarpidase) receives US regulatory approval&#8221; &#8212; SERB Pharmaceuticals\" data-secret=\"BsrbBfuceb\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/serb.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"BTG plc (LSE: BGC), the specialist healthcare company, today announces that it has received regulatory approval from the US Food and Drug Administration (FDA) for its Biologics License Application (BLA) for Voraxaze\u00ae(glucarpidase). The approval of Voraxaze\u00ae was granted under priority review, a designation that is given to therapies that offer major advances in treatment or [&hellip;]"}